secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2021-08-13T23:59:59+00:00
Accession:  0001193125-21-246082
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio appoints Patrick Soon-Shiong as Global Chief Scientific and Medical Officer; base salary $600k
--------------------------------------------------------------------------------

- Dr. Patrick Soon-Shiong appointed as Global Chief Scientific and Medical Officer, a new executive position, effective Aug 11, 2021.
- Soon-Shiong will also continue as Executive Chairman; receives base salary of $600k/year and bonus up to 50% of salary.
- CFO David Sachs gets base salary increase from $397k to $475k, effective next payroll period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312521246082/0001193125-21-246082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312521246082/d218269d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-246082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer